PLEKHA6 and non-small cell lung carcinoma: ENPP5, MCTP2, PLEKHA6, ANKRD29, SLC4A5, and CNTNAP2 were shown to play a role in malignancy other than NSCLC (Bralten et al., 2010; Langevin et al., 2012; Smith et al., 2012; Parris et al., 2014; Yang and Loh, 2019; Gopalakrishnan et al., 2020; Song et al., 2020; Sun et al., 2020; Chen et al., 2021b).